DK0616808T3 - Anvendelse af rifaximin og farmeaceutiske præparater indeholdende rifaximin til behandling af gastri sk dyspepsi forårsaget af Heliobacter pylori - Google Patents

Anvendelse af rifaximin og farmeaceutiske præparater indeholdende rifaximin til behandling af gastri sk dyspepsi forårsaget af Heliobacter pylori

Info

Publication number
DK0616808T3
DK0616808T3 DK94104308.5T DK94104308T DK0616808T3 DK 0616808 T3 DK0616808 T3 DK 0616808T3 DK 94104308 T DK94104308 T DK 94104308T DK 0616808 T3 DK0616808 T3 DK 0616808T3
Authority
DK
Denmark
Prior art keywords
rifaximin
treatment
pharmaceuticals containing
heliobacter pylori
dyspepsia caused
Prior art date
Application number
DK94104308.5T
Other languages
Danish (da)
English (en)
Inventor
Antonella Ferrieri
Leone Gabriele Rotini
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Application granted granted Critical
Publication of DK0616808T3 publication Critical patent/DK0616808T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK94104308.5T 1993-03-23 1994-03-18 Anvendelse af rifaximin og farmeaceutiske præparater indeholdende rifaximin til behandling af gastri sk dyspepsi forårsaget af Heliobacter pylori DK0616808T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93BO000099A IT1264494B1 (it) 1993-03-23 1993-03-23 Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter

Publications (1)

Publication Number Publication Date
DK0616808T3 true DK0616808T3 (da) 1996-09-30

Family

ID=11338806

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94104308.5T DK0616808T3 (da) 1993-03-23 1994-03-18 Anvendelse af rifaximin og farmeaceutiske præparater indeholdende rifaximin til behandling af gastri sk dyspepsi forårsaget af Heliobacter pylori

Country Status (11)

Country Link
US (1) US5352679A (es)
EP (1) EP0616808B1 (es)
JP (1) JP2755550B2 (es)
KR (1) KR0177846B1 (es)
AT (1) ATE142495T1 (es)
CA (1) CA2115381C (es)
DE (1) DE69400493T2 (es)
DK (1) DK0616808T3 (es)
ES (1) ES2091649T3 (es)
GR (1) GR3020984T3 (es)
IT (1) IT1264494B1 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6902738B2 (en) * 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
WO1996024341A1 (en) * 1995-02-07 1996-08-15 Narayan Krishnarao Athanikar Concomitant treatment with bismuth and antibacterials
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US5981522A (en) * 1995-09-01 1999-11-09 Kaneka Corporation Treatment of disease caused by infection of Helicobacter
IT1290679B1 (it) * 1997-02-14 1998-12-10 Alfa Wassermann Spa Uso della rifaximina e delle composizioni farmaceutiche che la contengono nel trattamento della diarrea da criptosporidiosi.
TW534813B (en) * 1997-02-28 2003-06-01 Kaneka Corp Treating agent for diseases due to infection with helicobacter
AU2002360416A1 (en) * 2001-11-21 2003-06-10 Activbiotics, Inc. Targeted therapeutics and uses thereof
AU2002364162A1 (en) * 2001-12-13 2003-06-30 Activbiotics, Inc. Sulfhydryl rifamycins and uses thereof
US7820652B2 (en) * 2003-09-24 2010-10-26 Activbiotics Pharma, Llc Regimen for the administration of rifamycin-class antibiotics
US8003118B2 (en) * 2005-03-02 2011-08-23 Kodsi Robert E Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
US20060210492A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Use of rifaximin for treatment and prevention of periodontal conditions
US20060210483A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
EP1698630B1 (en) 2005-03-03 2014-09-03 ALFA WASSERMANN S.p.A. New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
ITBO20050123A1 (it) * 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
US20080161337A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Chronic Prostatitis
EP2837378A1 (en) † 2007-07-06 2015-02-18 Lupin Limited Pharmaceutical compositions of rifaximin
PT2327407E (pt) 2008-09-26 2014-09-10 Aska Pharm Co Ltd Agentes profiláticos e/ou terapêuticos para desordens gastrointestinais funcionais
PL3628319T3 (pl) 2008-10-02 2024-04-29 Salix Pharmaceuticals, Ltd. Leczenie encefalopatii wątrobowej za pomocą ryfaksyminy
US20110035232A1 (en) * 2008-10-02 2011-02-10 Salix Pharmaceuticals, Ltd. Methods of treating hepatic encephalopathy
WO2010044093A1 (en) * 2008-10-16 2010-04-22 Strides Arcolab Limited Formulations containing rifaximin
RU2012126080A (ru) 2009-11-23 2013-12-27 Сипла Лимитед Местная пенообразующая композиция
JP2013511570A (ja) 2009-11-23 2013-04-04 シプラ・リミテッド 局所用泡沫組成物
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
US20130315988A1 (en) 2010-09-13 2013-11-28 Cipla Limited Pharmaceutical Composition
WO2012076832A1 (en) 2010-12-09 2012-06-14 Cipla Limited Suppositories comprising rifaximin
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
EP2927235B1 (en) 2014-03-31 2017-02-08 Euticals S.P.A. Polymorphic mixture of rifaximin and its use for the preparation of solid formulations
SI3546464T1 (sl) 2014-05-12 2020-09-30 Alfasigma S.P.A. Priprava in uporaba rifaksimina v kristalni obliki TAU solvatiranega z degme
CN106999477B (zh) * 2014-06-30 2020-04-10 萨利克斯药品公司 用于重复治疗肠易激综合征(ibs)的方法
CN110087688B (zh) 2016-10-14 2023-05-05 希普拉有限公司 包含利福昔明的药物组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1154655B (it) * 1980-05-22 1987-01-21 Alfa Farmaceutici Spa Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Also Published As

Publication number Publication date
GR3020984T3 (en) 1996-12-31
IT1264494B1 (it) 1996-09-24
ATE142495T1 (de) 1996-09-15
JPH06298768A (ja) 1994-10-25
JP2755550B2 (ja) 1998-05-20
US5352679A (en) 1994-10-04
ITBO930099A1 (it) 1994-09-23
ITBO930099A0 (it) 1993-03-23
KR0177846B1 (ko) 1999-03-20
CA2115381A1 (en) 1994-09-24
EP0616808A1 (en) 1994-09-28
EP0616808B1 (en) 1996-09-11
CA2115381C (en) 1999-01-05
DE69400493T2 (de) 1997-01-23
ES2091649T3 (es) 1996-11-01
DE69400493D1 (de) 1996-10-17

Similar Documents

Publication Publication Date Title
DK0616808T3 (da) Anvendelse af rifaximin og farmeaceutiske præparater indeholdende rifaximin til behandling af gastri sk dyspepsi forårsaget af Heliobacter pylori
UA32525C2 (uk) Стійка до шлункового соку форма лікарського засобу на основі пантопразолу для орального введення
WO2004032909A3 (en) Stabilized pharmaceutical composition containing basic excipients
HU9700589D0 (en) Extended release formulation
DE59707812D1 (de) Opioidantagonisthaltige galenische formulierung
ITMI912212A0 (it) Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica
DK0528734T3 (da) Thiaxolidin-2,4-dionderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
CA2108455A1 (en) Pharmaceutical compositions against gastric disorders
WO2004043430A3 (en) Botulinum toxin formulations for oral administration
DK0841903T3 (da) Orale farmaceutiske præparater indeholdende antimikrobielt virksomme aktivstoffer og sustained release pantoprazol
CA2315408A1 (en) A double capsule for the administration of active principles in multiple therapies
IL96995A0 (en) Pharmaceutical compositions containing pimobendan and their preparation
HK1067299A1 (en) Pharmaceutical compositions containing terbinafineand use thereof
WO1992018111A3 (en) Pharmaceutical composition for the treatment of gastritis
DE69927584D1 (de) Pharmazeutische zubereitungen zur behandlung von magengeschwüren
DK0655249T3 (da) Moenomycin som lægemiddel til behandling af mavesår
TR199800421A2 (xx) Moenomisin grubu antibiyotiklerin bizmut tuzlar�.
DE515995T1 (de) N-(5-thioxo-l-propyl)-l-cystein und derivate, deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen.
GEP20043377B (en) Pharmaceutical Complex
MY141008A (en) Oral formulations of deoxypeganine and their uses
RU2003133155A (ru) Способ эрадикации инфекции helicobacter pylori в желудке
FI952765A (fi) Desogestreeliä sisältävä tabletti, kapseli tai rae
DE59501945D1 (de) Orale Arzeimittelzubereitung enthaltend Diclofenac-Natrium und eine organische Säure
DK0612763T3 (da) Cykliske angiopeptinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0946585T3 (da) Steroidforbindelser substitueret i stilling 11, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf